Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Brown & Brown
BRO
$24B
| $88.4M | 0.03% |
1,593,457
+440,592
| +38% | +$24.6M |
|
552
Schwab US TIPS ETF
SCHP
$16.2B
| $88.1M | 0.03% |
2,816,208
-295,390
| -9% | -$9.32M |
|
553
First Industrial Realty Trust
FR
$8.38B
| $88M | 0.03% |
1,690,428
+56,596
| +3% | +$3.08M |
|
554
Cloudflare
NET
$110B
| $88M | 0.03% |
780,940
-650,265
| -45% | -$77.7M |
|
555
Okta
OKTA
$26.1B
| $87.9M | 0.03% |
370,561
+5,447
| +1% | +$1.35M |
|
556
CF Industries
CF
$17.8B
| $87.8M | 0.03% |
1,573,581
+37,149
| +2% | +$1.78M |
|
557
Seagate
STX
$187B
| $87.6M | 0.03% |
1,061,914
+20,860
| +2% | +$1.81M |
|
558
Fortune Brands Innovations
FBIN
$5.98B
| $87.1M | 0.03% |
1,139,699
+25,699
| +2% | +$2.14M |
|
559
Deckers Outdoor
DECK
$12.8B
| $86.8M | 0.03% |
1,445,880
-458,040
| -24% | -$31.4M |
|
560
Evercore
EVR
$11.6B
| $86.3M | 0.03% |
645,405
-56,041
| -8% | -$7.62M |
|
561
Elanco Animal Health
ELAN
$11.4B
| $86.3M | 0.03% |
2,704,832
+92,110
| +4% | +$3.09M |
|
562
Zurn Elkay Water Solutions
ZWS
$8.58B
| $86.2M | 0.03% |
2,782,438
+602,318
| +28% | +$16.9M |
|
563
Flowers Foods
FLO
$1.53B
| $85.9M | 0.03% |
3,636,307
-116,398
| -3% | -$2.76M |
|
|
SGI
564
Somnigroup International
SGI
$13.8B
| $85.9M | 0.03% |
1,851,128
+502,352
| +37% | +$21.9M |
|
|
MRO
565
DELISTED
Marathon Oil Corporation
MRO
| $85.7M | 0.03% |
6,272,045
-40,729
| -0.6% | -$491K |
|
566
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.74B
| $85M | 0.03% |
805,084
+39,623
| +5% | +$4.29M |
|
567
C.H. Robinson
CHRW
$17B
| $85M | 0.03% |
976,619
+315,524
| +48% | +$28.5M |
|
568
F5
FFIV
$23.5B
| $84.6M | 0.03% |
425,689
+13,554
| +3% | +$2.71M |
|
569
Lattice Semiconductor
LSCC
$17.8B
| $84.6M | 0.03% |
1,308,114
+318,440
| +32% | +$18.8M |
|
570
W.W. Grainger
GWW
$61.3B
| $84.5M | 0.03% |
215,087
+3,207
| +2% | +$1.39M |
|
571
Pentair
PNR
$10.7B
| $84.5M | 0.03% |
1,162,924
+22,958
| +2% | +$1.71M |
|
|
HZNP
572
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $84.3M | 0.03% |
769,497
-21,834
| -3% | -$2.27M |
|
573
Alcoa
AA
$14.2B
| $84.2M | 0.03% |
1,720,424
+322,126
| +23% | +$13.6M |
|
574
Brixmor Property Group
BRX
$9.12B
| $84.2M | 0.03% |
3,807,713
+113,070
| +3% | +$2.6M |
|
575
Manhattan Associates
MANH
$11.3B
| $84.1M | 0.03% |
549,409
-4,974
| -0.9% | -$776K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.